Home
Centre for Cancer Biomarkers CCBIO
Seminar

CCBIO Seminar June 11, 2026 - Ricardo Coletta

Welcome to the CCBIO seminar series in the spring term of 2026! Open to all in the auditorium in Armauer Hansens Hus. No registration necessary. Speaker is Ricardo Coletta, Universidade Estadual de Campinas (UNICAMP), Brazil.

The CCBIO Seminars logo on top of a picture from the auditorium with audience and a speaker.
Photo:
CCBIO, Agnete Engelsen

Main content

Speaker

Professor Ricardo Coletta, Universidade Estadual de Campinas (UNICAMP), Brazil

Ricardo D. Coletta has been Professor of Oral Pathology in the Department of Oral Diagnosis at UNICAMP School of Dentistry at Piracicaba since 2017 and currently serves as a Visiting Professor in the research group of prof Tuula Salo in the Department of Oral and Maxillofacial Diseases at the Faculty of Medicine, University of Helsinki. His research focuses on the cellular and molecular mechanisms underlying oral cancer tumorigenesis, with an emphasis on identifying biomarkers that may improve treatment strategies and prognostic assessment.

Title

Biomarkers in Oral Cancer: From Discovery to Clinical Impact

When

June 11, 2026, at 14.30–15.30

Chair

Daniela Costea

Place

The auditorium in Armauer Hansens Hus (external link)

No registration necessary. Note that if you are a UiB student and need the ECTS for participation, you need to have registered in Studentweb for this term.

Abstract

This presentation will examine the landscape of biomarker discovery in oral squamous cell carcinoma (OSCC), integrating histopathological, proteomic, and molecular approaches. I will highlight recent advances in histopathological biomarkers, including tumor budding, stromal activation, and other microenvironment‑driven prognostic indicators. The talk will also explore proteomic‑based biomarker identification, emphasizing how large‑scale protein profiling can uncover pathways associated with tumor aggressiveness, survival, and therapeutic vulnerability. Finally, I will discuss the development and characterization of cisplatin‑resistant OSCC cell lines, focusing on their epithelial-mesenchymal transition signature and its relevance for predicting treatment response and identifying resistance‑related biomarkers.